a Department of Drug Metabolism and Pharmacokinetics , Genentech, Inc , South San Francisco , CA , USA.
b Department of Biochemistry and Molecular Biology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
Drug Metab Rev. 2018 Aug;50(3):221-255. doi: 10.1080/03602532.2018.1473875. Epub 2018 Jun 28.
This annual review is the third one to highlight recent advances in the study and assessment of biotransformations and bioactivations ( Table 1 ). We followed the same format as the previous years with selection and authoring each section (see Baillie et al. 2016 ; Khojasteh et al. 2017 ). We acknowledge that many universities no longer train students in mechanistic biotransformation studies reflecting a decline in the investment for those efforts by public funded granting institutions. We hope this work serves as a resource to appreciate the knowledge gained each year to understand and hopefully anticipate toxicological outcomes dependent on biotransformations and bioactivations. This effort itself also continues to evolve. I am pleased that Drs. Rietjens and Miller have again contributed to this annual review. We would like to welcome Kaushik Mitra as an author for this year's issue, and we thank Deepak Dalvie for his contributions to last year's edition. We have intentionally maintained a balance of authors such that two come from an academic setting and two come from industry. As always, please drop us a note if you find this review helpful. We would be pleased to hear your opinions of our commentary, and we extend an invitation to anyone who would like to contribute to a future edition of this review.
这是第三篇重点介绍生物转化和生物活化研究和评估最新进展的年度综述(表 1)。我们沿用了前几年的格式,选择和撰写每一部分(见 Baillie 等人,2016;Khojasteh 等人,2017)。我们认识到,许多大学不再培训学生进行机制性生物转化研究,这反映了公共资助机构对这些努力的投资减少。我们希望这项工作能成为一个资源,让大家每年都能了解并希望预测依赖生物转化和生物活化的毒理学结果。这项工作本身也在不断发展。我很高兴 Rietjens 博士和 Miller 博士再次为这一年的综述做出贡献。我们欢迎 Kaushik Mitra 成为今年的作者,也感谢 Deepak Dalvie 对去年版本的贡献。我们有意保持作者之间的平衡,其中两位来自学术机构,两位来自工业界。一如既往,如果您觉得这篇综述有帮助,请给我们留言。我们很乐意听取您对我们评论的意见,并邀请任何有兴趣为未来的这篇综述做出贡献的人。